147 related articles for article (PubMed ID: 15177871)
1. TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD).
Peitz U; Kouznetsova I; Wex T; Gebert I; Vieth M; Roessner A; Hoffmann W; Malfertheiner P
Peptides; 2004 May; 25(5):771-7. PubMed ID: 15177871
[TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
[TBL] [Abstract][Full Text] [Related]
3. Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study.
Pieramico O; Zanetti MV
Dig Liver Dis; 2000 Oct; 32(7):567-72. PubMed ID: 11142553
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
5. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
[TBL] [Abstract][Full Text] [Related]
8. Metaplasia of the duodenum shows a Helicobacter pylori-correlated differentiation into gastric-type protein expression.
Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Dekker J
Hum Pathol; 2003 Feb; 34(2):156-65. PubMed ID: 12612884
[TBL] [Abstract][Full Text] [Related]
9. Localization of TFF3 peptide in human esophageal submucosal glands and gastric cardia: differentiation of two types of gastric pit cells along the rostro-caudal axis.
Kouznetsova I; Kalinski T; Peitz U; Mönkemüller KE; Kalbacher H; Vieth M; Meyer F; Roessner A; Malfertheiner P; Lippert H; Hoffmann W
Cell Tissue Res; 2007 May; 328(2):365-74. PubMed ID: 17216196
[TBL] [Abstract][Full Text] [Related]
10. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.
Labouvie C; Machado JC; Carneiro F; Sarbia M; Vieth M; Porschen R; Seitz G; Blin N
J Cancer Res Clin Oncol; 1999; 125(2):71-6. PubMed ID: 10190312
[TBL] [Abstract][Full Text] [Related]
12. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
Hackelsberger A; Günther T; Schultze V; Manes G; Dominguez-Muñoz JE; Roessner A; Malfertheiner P
Gut; 1998 Jul; 43(1):17-21. PubMed ID: 9771400
[TBL] [Abstract][Full Text] [Related]
13. Expression of trefoil peptides in the subtypes of intestinal metaplasia.
Kim BW; Kim KM; Lee BI; Maeng LS; Choi H; Cho SH; Chae HS; Kim JK; Choi KY; Chung IS
Peptides; 2004 May; 25(5):779-83. PubMed ID: 15177872
[TBL] [Abstract][Full Text] [Related]
14. Pathology of the gastroesophageal junction.
Odze RD
Semin Diagn Pathol; 2005 Nov; 22(4):256-65. PubMed ID: 16939053
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
[TBL] [Abstract][Full Text] [Related]
16. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.
Malfertheiner P; Peitz U
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i13-20. PubMed ID: 15711003
[TBL] [Abstract][Full Text] [Related]
17. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
Morales CP; Spechler SJ
Am J Gastroenterol; 2003 Apr; 98(4):759-62. PubMed ID: 12738452
[TBL] [Abstract][Full Text] [Related]
18. [Intestinal metaplasia at the esophagogastric junction. Prevelence and association in patients undergoing endoscopy].
Castro ML; Fachal C; Pineda JR; Domínguez F; Prada JI; Hermo JA; Suso J; Clofent J
Gastroenterol Hepatol; 2002 Oct; 25(8):487-92. PubMed ID: 12361529
[TBL] [Abstract][Full Text] [Related]
19. Carditis: all Helicobacter pylori or is there a role for gastro-oesophageal reflux?
McNamara D; Buckley M; Crotty P; Hall W; O'Sullivan M; O'Morain C
Scand J Gastroenterol; 2002 Jul; 37(7):772-7. PubMed ID: 12190089
[TBL] [Abstract][Full Text] [Related]
20. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group.
Voutilainen M; Färkkilä M; Juhola M; Nuorva K; Mauranen K; Mäntynen T; Kunnamo I; Mecklin JP; Sipponen P
Am J Gastroenterol; 1999 Apr; 94(4):913-8. PubMed ID: 10201456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
